Fernando Martinez
Joseph D. Early Chair in Biomedical Research, Pulmonary Medicine University of Massachusetts Medical School
Seminars
Wednesday 20th August 2025
Stratifying Patients for Improved Trial Outcomes – High-Risk vs Low-Risk in the Maverick IPF Survival Trial
1:30 pm
- Exploring the premise of stratifying patients by risk level (high vs low)
- Shifting focus from FVC decline to survival as a primary endpoint in clinical trials, and how this could offer more meaningful insights into treatment efficacy for IPF
- Discussing the role of proteomics and biomarkers in identifying high-risk patients and optimizing trial design to better reflect patient populations likely to benefit from treatment.
Wednesday 20th August 2025
Panel Discussion: Hear from the Clinicians – What Will Constitute First-Line Therapy for IPF in an Evolving Landscape?
3:30 pm
With new therapies on the horizon, the IPF treatment landscape is evolving. This panel brings together leading clinicians and academics to explore how emerging drugs will fit into current treatment paradigms. Experts will discuss the clinical decision-making process for first-line therapy, balancing efficacy, safety, and patient-specific factors.
Wednesday 20th August 2025
Chairs Opening Remarks
8:15 am
Thursday 21st August 2025
Chairs Opening Remarks
8:25 am
Wednesday 20th August 2025
Chairs Closing Remarks
5:45 pm
Thursday 21st August 2025
Chair’s Closing Remarks
4:50 pm
